Lv41
428 积分 2022-06-09 加入
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial
6小时前
已完结
Fine tuning towards the next generation of engineered T cells
22天前
已完结
A guide to complement biology, pathology and therapeutic opportunity
22天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
23天前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
25天前
已完结
B cell-activating factor and its targeted therapy in autoimmune diseases
28天前
已完结
Advances in the treatment of systemic lupus erythematosus
28天前
已完结
Immunotherapy Strategies for Systemic Lupus Erythematosus: Focusing on CAR-T Cell Therapy
28天前
已完结
CAR T-cell therapy in SLE: A systematic review
28天前
已完结
CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy
29天前
已完结
皖公网安备34019202002308
